Navigation Links
Fuse Science, Inc. DROPS Now Available at PoweredByFuse.com
Date:12/4/2012

MIAMI LAKES, Fla., Dec. 4, 2012 /PRNewswire/ -- Fuse Science, Inc. (OTCQB: DROP), (www.fusescience.com) an innovative consumer products company that is developing new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals, is pleased to announce that this week's web launch of its PowerFuse™ and ElectroFuse™ DROP products has been met with tremendous excitement.  Both products are now available, along with the Company's EnerJel™ product, on the Powered By Fuse website, www.poweredbyfuse.com.  PowerFuse™ is "All the Energy You Need in a Single DROP™" and ElectroFuse™ is "All the Electrolytes You Need in a Single Drop™." 

"We have been working diligently to insure our launch of the DROP product was a success," said Brian Tuffin, CEO of Fuse Science.  "We feel that both products will redefine their categories.  Our PowerFuse™ product is the 'Evolution of Energy™' while our ElectroFuse™ product will help boost your electrolytes before you compete.  We understand the size and scope of these consumer markets and we are confident that our sporting goods retail distribution strategy will hit our primary demographic with these product."

PowerFuse™
PowerFuse™ is Fuse Science's first Energy formula in a drop.  Administered quickly and easily in the mouth, it allows for optimal absorption, so that you feel energized and are able to perform at your natural best throughout the game, workout or day.  PowerFuse™ contains natural ingredients, causes no sugar crash with zero calories and less than half the caffeine of an 8 oz. cup of premium coffee.  It is available in a great tasting Berry Blast flavor.

ElectroFuse™
ElectroFuse™ is Fuse Science's first Electrolyte formula in a drop.  Administered quickly and easily in the mouth, it allows for optimal absorption of the electrolytes.
ElectroFuse™ contains natural ingredients, causes no sugar crash with zero calories, is easily portable and is available in a great tasting Salty-Sweet flavor.

For additional information on the DROPS including recommended use, please visit: www.poweredbyfuse.com/introducing-powerfuse-and-electrofuse.

Fuse is prioritizing the production of PowerFuse™ and ElectroFuse™ for the planned retail launch and distribution of the DROPS, which is scheduled to begin in January 2013.  The Company is anticipating a high demand for the products and as a result, on-line availability could be limited.  Inventory for on-line ordering will expand as retail placement becomes fulfilled.

"We continue to accelerate production to meet demand and we are positioning ourselves strategically with our manufacturing, marketing and third party logistic partners to effectively meet retail demand which will begin appearing in January," added Tuffin.

If you still don't know what it means to be "Powered By Fuse™" then it's time. Go to www.poweredbyfuse.com and learn more about the products and the company.

About Fuse Science, Inc.
Fuse Science, Inc. (OTCQB: DROP), is an innovative consumer products holding company based in Miami Lakes, Florida.  Fuse Science holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals.  The company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly - all in a concentrated "DROP" form that is simply applied under the tongue.  The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products.  Information about Fuse Science is available online at www.fusescience.com and www.poweredbyfuse.com or by calling 305-503-FUSE (3873).For more information:To schedule an interview:Fuse Science, Inc.Gus DeQuesadaInvestor RelationsMichelsen AdvertisingDirect: (305) 503-3873, Ext. 2

C-305-733-1410 / 786-488-7138Email: ir@fusescience.com

prnews@michelsenadvertising.com Safe Harbor Statement: Certain statements and information included in this release may constitute "forward-looking statements" as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management's projections, estimates and expectations is contained in the Company's SEC filings. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.


'/>"/>
SOURCE Fuse Science, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
2. In basic science, sometimes it takes individual benefactors like Roys Poyiadjis to fuel innovation
3. Rep. Fattah Announces More Than $10.7 Million in Grants for Neuroscience, Scientific and Medical Research in Philadelphia
4. Fuse Science, Inc. adds Major General Robert Dickerson (Ret.) to its Advisory Board
5. Drugs.com Releases Q3 Sales for Top 100 U.S. Drugs: Singulair Drops But Nexium and Abilify Remain the Leading Brands
6. New Reproductive Support Dietary Supplement, Pregnitude™, Now Available For Women Having Difficulty Conceiving
7. Provectus Pharmaceuticals, Inc.s Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
8. Anatabloc® Retail Expansion with GNC Complete: Product Now Available at all GNC Corporate Stores and GNC.com
9. New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets
10. FUJIFILM Synapse® Mobility 3.0 Now Available In The U.S.
11. Telescope Implant for End Stage Macular Degeneration Now Available Across the Nation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2017)... -- Exactly 50 years ago today, the Monterey Pop Festival opened ... the San Francisco "Summer of Love."  To celebrate the anniversary, ... in strategic market research portals that it will begin delivering ... Northern Light,s "Summer of Love (For Our Customers)."  ... ...
(Date:6/14/2017)... , June 14, 2017  In 2016, Embodied ... Startups pitch competition and came away with $25,000 ... is described by Forbes as "entering the life of ... Association as teaching "empathy to medical professionals in an ... was recently named a finalist for the Department of ...
(Date:6/11/2017)...  Eli Lilly and Company (NYSE: LLY ) ... of galcanezumab, an investigational treatment for the prevention of ... key secondary endpoints for galcanezumab compared to placebo at ... EVOLVE-2 and REGAIN) will be presented today at the ... Boston . "The detailed ...
Breaking Medicine Technology:
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... consulting firm servicing communities throughout the greater Cincinnati metropolitan area, is teaming up ... temporary lodgings for families with children receiving treatment in nearby hospitals. , Ronald ...
(Date:6/27/2017)... London UK (PRWEB) , ... June 27, 2017 , ... ... a clinical study is whether they can trust the sponsor to pay them correctly ... vital that sponsors and CROs establish payment strategies that encourage sites to work on ...
(Date:6/27/2017)... ... , ... The Congressional Budget Office (CBO) projects that the Better Care Reconciliation ... and Affordable Care Act (ACA), would result in 22 million Americans losing their health ... More than 20 million Americans have gained health insurance under the ACA, and from ...
(Date:6/27/2017)... ... 27, 2017 , ... A January 18th article on medGadget reports ... billion by the year 2024 according to a new report. The article also notes ... from titanium. Los Angeles area clinic Beverly Hills Periodontics & Dental Implant Center says ...
(Date:6/27/2017)... New York, NY (PRWEB) , ... June 27, ... ... communications and marketing experts to contribute to an upcoming case studies guidebook. This ... or her organization. , This book will include articles, case studies and how-to’s ...
Breaking Medicine News(10 mins):